IJDVL Close
 

Figure 5: (a) Immunohistochemical features of the primary tumor, with CD31-positive cells. Magnification ×400. (b) Immunohistochemical features of the primary tumor, with CD34-positive cells. Magnification ×400. (c) Immunohistochemical features of the primary tumor, with D2-40-positive cells. Magnification ×400. (d) Immunohistochemical features of the primary tumor, with ETS-related gene (ERG)-positive cells. Magnification ×400. (e) Immunohistochemical features of the primary tumor, with factor VIII-related antigen cells. Magnification ×400 (f) Immunohistochemical features of the primary tumor, with Ki67-positive (~10%) cells. Magnification ×400

Figure 5: (a) Immunohistochemical features of the primary tumor, with CD31-positive cells. Magnification ×400. (b) Immunohistochemical features of the primary tumor, with CD34-positive cells. Magnification ×400. (c) Immunohistochemical features of the primary tumor, with D2-40-positive cells. Magnification ×400. (d) Immunohistochemical features of the primary tumor, with ETS-related gene (ERG)-positive cells. Magnification ×400. (e) Immunohistochemical features of the primary tumor, with factor VIII-related antigen cells. Magnification ×400 (f) Immunohistochemical features of the primary tumor, with Ki67-positive (~10%) cells. Magnification ×400